QUOTE AND NEWS
StreetInsider.com  Jul 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioCryst+Pharma+%28BCRX%29+Receives+Additiona+Funds+from+HHS+for+Peramivir+Testing/9628871.html for the full story.
Benzinga  Jun 23  Comment 
In a research note released Monday, Wells Fargo analyst Brian Abrahams upgraded BioCryst Pharmaceuticals (NASDAQ: BCRX) to Outperform from Market Perform and increased his valuation range from $17 to $19 (originally $8 to $9). The analyst...
StreetInsider.com  Jun 23  Comment 
UPGRADES Janney Montgomery Scott raises Express Inc. (NYSE: EXPR) from Neutral to Buy with a price target of $20. Click Here for more color. Evercore Partners boosts BlackBerry (Nasdaq: BBRY) from Underweight to Equal Weight and adjusts its...
StreetInsider.com  Jun 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioCryst+Pharma+%28BCRX%29%2C+HHS+Extend+Agreement+30+Days/9558732.html for the full story.
Benzinga  May 28  Comment 
In a report published Wednesday, Bank of America analyst Steve Byrne reiterated an Underperform rating on BioCryst Pharmaceuticals (NASDAQ: BCRX), and raised the price target from $8.00 to $9.00. In the report, Bank of America noted, “As we...
Benzinga  May 28  Comment 
DSW (NYSE: DSW) dropped 19.31% to $26.24 in pre-market trading after the company reported weaker-than-expected fiscal first-quarter results and lowered its full-year earnings forecast. Sungy Mobile (NASDAQ: GOMO) dipped 11.23% to $12.41 in...
StreetInsider.com  May 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioCryst+Pharmaceuticals%2C+Inc.+%28BCRX%29+Awards+All+Employees+Bonus+Totaling+%241M%3B+Cites+BCX4161+OPuS-1+Trial/9525347.html for the full story.
Benzinga  May 27  Comment 
Midway through trading Tuesday, the Dow traded up 0.39 percent to 16,670.76 while the NASDAQ surged 0.86 percent to 4,221.94. The S&P also rose, gaining 0.47 percent to 1,909.51. Leading and Lagging Sectors Financial sector was the top...
TheStreet.com  May 27  Comment 
NEW YORK (TheStreet) -- BioCryst Pharmaceuticals  rose Tuesday after the company announced its experimental drug for treating a rare immune disorder was effective in decreasing the disease's attacks in a mid-stage trial. The trial compared the...
Benzinga  May 27  Comment 
Spherix (NASDAQ: SPEX) rose 28.47% to $1.94. Spherix noted that the US Senate, and Senate Judiciary Committee Chairman Patrick Leahy (D-Vermont), removed the patent reform bill from the committee's calendar. The Hillshire Brands Company (NYSE:...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki